VAQTA (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the VAQTA drug offered from Merck Sharp & Dohme Corp.. This Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: hepatitis A vaccine, inactivated
SUBSTANCE NAME: HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)
TYPE: VACCINE
PHARMA CLASS: Inactivated Hepatitis A Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis A Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient]
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1996-03-29
END MARKETING DATE: 0000-00-00


VAQTA VACCINE Details:

Item DescriptionVAQTA from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 25([iU]/.5mL)
START MARKETING DATE: 1996-03-29
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0006-4095_9ae11ba9-4ab4-476e-82ad-921333bbdb7d
PRODUCT NDC: 0006-4095
APPLICATION NUMBER: BLA103606

Other HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED) Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.VAQTA